Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00403 | NHS-PEG12-azide | 1610796-02-5 |
| NHS-PEG12-azide is a vital tool in the biomedical industry. It serves as a linker for bioconjugation, allowing efficient attachment of azide groups to biomolecules. This product facilitates the development of targeted drug delivery systems, diagnostic probes, and bioimaging agents. It finds applications in treating various diseases such as cancer, cardiovascular disorders, and infectious diseases. | Inquiry | |
| BADC-00404 | Azido-PEG4-PFP ester | 1353012-00-6 |
| Azido-PEG4-PFP ester is a versatile chemical compound widely used in the biomedicine field. This ester derivative is utilized for the modification and functionalization of biomolecules, such as peptides and proteins. Its azido group allows for further conjugation or attachment to various drugs, biomaterials, or surfaces. This enables targeted drug delivery, protein labeling, and immunoassays for disease diagnostics and therapeutics. | Inquiry | |
| BADC-00406 | Azido-PEG3-PFP ester | 1807530-07-9 |
| Azido-PEG3-PFP ester is a key tool for biomolecule modification. By facilitating azide group conjugation with target molecules, it imparts a platform for seamless bioorthogonal labeling and imaging throughout diverse biological frameworks. Its versatile employment encompasses drug delivery, proteomics, and bioconjugation strategies, unveiling a profound comprehension of cellular pathways and disease mechanisms. | Inquiry | |
| BADC-00407 | Azido-PEG3-NHS ester | 1245718-89-1 |
| Azido-PEG3-NHS ester is a non-cleavable 3-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs). | Inquiry | |
| BADC-00408 | Azido-PEG2-PFP ester | 1393330-37-4 |
| Azido-PEG2-PFP ester is a mixture of azide-functionalized polyethylene glycol (PEG) derivatives interleaved with pentafluorophenyl (PFP) ester moieties. This special compound is widely used as a coupling agent in the field of bioconjugation chemistry and shows unparalleled potential in efficient biomolecule modification. Whether proteins or peptides, azido-PEG2-PFP esters open up many possibilities for revolutionary applications, including drug delivery systems, targeted therapies, and transformative diagnostics. | Inquiry | |
| BADC-00411 | 5-azidopentanoic acid N-hydroxysuccinimide ester | 478801-48-8 |
| 5-azidopentanoic acid N-hydroxysuccinimide ester is an important entity in the biomedical field and plays a key role. This compound has multiple uses as a catalyst for bioconjugation and protein labeling, triggering the specific binding of a drug or biomolecule to its intended receptor. This advantage ultimately facilitates the delivery of targeted drugs while refining diagnostic methods. | Inquiry | |
| BADC-00412 | 3-azidopropanoate-N-hydroxysuccinimide ester | 850180-76-6 |
| 3-azidopropanoate-N-hydroxysuccinimide ester is a small molecule reagent. As a versatile reactive reagent, it has a significant impact on bioconjugation and cross-linking applications. It is deeply embedded in the synthetic mechanism of drug delivery systems, effectively achieving precise targeted release of therapeutic drugs. | Inquiry | |
| BADC-00413 | NHS-Ac-N3 | 824426-32-6 |
| NHS-Ac-N3 is a paramount reagent within biomedicine and emerges as an exquisite modulator for drug advancement and biomolecule conjugation. This compound has unique chemical properties that play a key role in the fusion of multiple drugs and bioconjugates, aiding in the development of effective treatments for diseases such as cancer, neurodegenerative diseases, and infectious diseases. | Inquiry | |
| BADC-00414 | endo-BCN-PEG4-PFP ester | 1421932-52-6 |
| Inquiry | ||
| BADC-00416 | endo-BCN-PEG3-PFP ester | 2101206-48-6 |
| Inquiry | ||
| BADC-00417 | endo-BCN-PEG3-NHS ester | 2101206-94-2 |
| Inquiry | ||
| BADC-00418 | endo-BCN-PEG2-PFP ester | 1421932-53-7 |
| Inquiry | ||
| BADC-00419 | 2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10-trioxa-4-azatridecan-13-oate | 2243565-12-8 |
| 2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10-trioxa-4-azatridecan-13-oate is a small molecule compound with biological activity. It has been widely studied as a linker in ADC development. | Inquiry | |
| BADC-00420 | perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate | |
| Perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate is an exquisite biomedical chemical. Its extraordinary attributes make it a prime candidate for drug delivery systems, facilitating targeted release of therapeutic agents. By enabling precise localization within the body, it exhibits remarkable prowess in combating diverse conditions. | Inquiry | |
| BADC-00421 | 2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate | |
| 2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate is a highly intricate and multifaceted substance that emerges as an exceedingly powerful agent employed within the biomedical realm. Manifesting its efficacy in combating a myriad of ailments including cancer, inflammation, and bacterial infections, this compound boasts the capacity to extensively navigate and perturb distinct biochemical routes intrinsic to cellular mechanisms. | Inquiry | |
| BADC-00422 | perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate | |
| perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate is a biomedical product for cancer drug development. It exhibits potent inhibitory effects against specific tumor cells, enhancing their susceptibility to chemotherapy. This product's unique chemical properties aid in delivering targeted therapies to tumor sites, minimizing off-target effects. | Inquiry | |
| BADC-00423 | 2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate | |
| 2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate is a remarkable biomedical entity. Its capacity to impede specific signaling pathways associated with neoplastic proliferation and advancement has endowed it with considerable prospects for combating a myriad of cancers. Furthermore, the compound's exceptional attributes extend to its ability to combat multidrug-resistant microbial strains, thus reinforcing its significance in the relentless battle against infectious agents. | Inquiry | |
| BADC-00424 | perfluorophenyl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate | |
| Perfluorophenyl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate is a widely used biomedical agent. Due to its special chemical properties and composition, it represents a typical tool in the biomedical field. This exquisite entity has demonstrated its potential as a powerful drug, adept at effectively targeting unique cellular pathways and receptors responsible for treating a variety of diseases. | Inquiry | |
| BADC-00425 | 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate | |
| 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate is a pharmaceutical compound widely used in the biomedical field. Its powerful medicinal properties are effective against drug-resistant strains, especially in overcoming Gram-positive infections. | Inquiry | |
| BADC-00426 | Perfluorophenyl 2-(cyclooct-2-ynyloxy)acetate | 886209-60-5 |
| Perfluorophenyl 2-(cyclooct-2-ynyloxy)acetate is a cleavable ADC junction bridge for the synthesis of antibody drug conjugates (ADCs). It is a chemical compound used in click chemistry and bioconjugation applications. It features a cyclooctyne moiety, which is a reactive cyclic alkyne with a strained ring structure, making it highly reactive in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions. The O-PFP (pentafluorophenyl) ester group is a reactive functional group that facilitates the attachment of this molecule to other biomolecules or surfaces. This compound is often used for labeling, imaging, or creating bioconjugates in chemical biology and drug development. | Inquiry |
